Genomics stocks continue to lead the biotech sectors on a downward slide Wednesday morning.

Celera Genomics dropped another 4.7 percent by mid-day after shedding 7 percent Tuesday.Incyte Genomics slipped another 4 percent following a 4.2 percent decline the day before. And the market chipped an additional 5.4 percent of Affymetrix stock following a previous day decline of 5.1 percent.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

NPR reports on Human Cell Atlas Consortium's effort to catalog all the different cell types within the human body.

The Union of Concerned Scientists surveyed US government scientists about Trump Administration policies and more, Science reports.

National Geographic reports that marine mammals have lost a gene that could make them more susceptible to organophosphate damage.

In PNAS this week: history and genetic diversity of the scarlet macaw, approach for predicting human flu virus evolution, and more.